CHA2DS2-VA and non-CHA2DS2-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification
Frontiers in Cardiovascular Medicine · 20.07.2026 · 13
DOI: 10.3389/fcvm.2026.1884992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 20.07.2026. Verfasst von Kamilla Luca Dávid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Central Hospital of Northern Pest - Military Hospital, Budapest, Hungary. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Semmelweis Egyetem.
Abstract (Originalsprache)
Introduction
Typical atrial flutter (AFL) is associated with considerable morbidity and mortality despite high procedural success rates of cavotricuspid isthmus (CTI) ablation. While the CHA₂DS₂-VA score is widely used for thromboembolic risk assessment in atrial fibrillation, its prognostic value for long-term survival after CTI ablation remains unclear. Our objective therefore was to evaluate the association between the CHA₂DS₂-VA score, its individual components, and non-CHA₂DS₂-VA comorbidities with all-cause mortality following CTI ablation for typical AFL.
Methods
We retrospectively analyzed clinical and mortality data from 249 consecutive patients who underwent successful CTI ablation between July 2017 and December 2021. Kaplan-Meier survival analysis, Cox regression, and time-dependent ROC analyses were performed to evaluate predictors of all-cause mortality.
Results
During a mean follow-up of 1771 ± 635 days, 27% of patients died. Mortality increased progressively with higher CHA₂DS₂-VA scores, corresponding to a stepwise decline in survival (log-rank p < 0.001). A CHA₂DS₂-VA score ≥3 was identified as the optimal threshold for mortality prediction, with annual mortality rates of 1.4% versus 9.9% in patients with scores <3 and ≥3, respectively ( p < 0.001). The CHA₂DS₂-VA score demonstrated good discriminative ability (c-index = 0.73). In multivariable analysis, the CHA₂DS₂-VA score remained an independent predictor of all-cause mortality (HR 1.48, 95% CI 1.26 -1.75, p < 0.001). Among non-CHA₂DS₂-VA variables, pulmonary disease and obstructive sleep apnoea independently predicted adverse long-term survival, whereas female sex was not significantly associated with mortality.
Discussion
The CHA₂DS₂-VA score is an independent predictor of long-term all-cause mortality after CTI ablation for typical AFL, extending its clinical utility beyond thromboembolic risk assessment. Incorporation of selected non-CHA₂DS₂-VA comorbidities may further refine risk stratification and support individualized follow-up strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Central Hospital of Northern Pest - Military Hospital, Budapest, Hungary.
- Doctoral School of Clinical Medicine, Cardiovascular Medicine and Research Division, Semmelweis University, Budapest, Hungary.
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
Förderung
- Semmelweis Egyetem
Zitieren
APA
Dávid, K. L., Zsigmond, E. J., Bogdan, M., Polgár, B., Vigh, N., Gulyás, Z., Papp, J., Tóth-Zsámboki, E., & Duray, G. Z. (2026). CHA2DS2-VA and non-CHA2DS2-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1884992
Vancouver
Dávid KL, Zsigmond EJ, Bogdan M, Polgár B, Vigh N, Gulyás Z, et al. CHA2DS2-VA and non-CHA2DS2-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1884992
BibTeX
@article{Dvid2026,
author = {Dávid, Kamilla Luca and Zsigmond, Előd János and Bogdan, Manuella and Polgár, Balázs and Vigh, Nikolett and Gulyás, Zalán and Papp, Judit and Tóth-Zsámboki, Emese and Duray, Gábor Zoltán},
title = {CHA2DS2-VA and non-CHA2DS2-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1884992}
}
EUVIMED